Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ADC)
| ADC ID |
DRG0QFXWR
|
|||||
|---|---|---|---|---|---|---|
| ADC Name |
JP2024501894A5-20
|
|||||
| Synonyms |
JP2024501894A5-20
Click to Show/Hide
|
|||||
| Organization |
HANGZHOU DAC BIOTECH CO., LTD.
|
|||||
| Drug Status |
Investigative
|
|||||
| Drug-to-Antibody Ratio |
6.9
|
|||||
| Structure |
|
|||||
| Antibody Name |
B7-H4 2F9V18
|
Antibody Info | ||||
| Antigen Name |
V-set domain-containing T-cell activation inhibitor 1 (VTCN1)
|
Antigen Info | ||||
| Payload Name |
Undisclosed
|
|||||
| Therapeutic Target |
Stimulator of interferon genes protein (STING1)
|
Target Info | ||||
| Linker Name |
Undisclosed
|
|||||
| Conjugate Type |
Random conjugation through reduced inter-chain cysteines.
|
|||||